Login / Signup

Pharmacokinetics and Safety of Vedolizumab Following Administration of a Single Intravenous Dose in Healthy Chinese Subjects.

Ran XieNan ZhaoBo JiaXia ZhaoYi Min CuiHiroyuki OkamotoLili YangAlexander Prokopienko
Published in: European journal of drug metabolism and pharmacokinetics (2022)
http://www.chinadrugtrials.org.cn : CTR20171528.
Keyphrases
  • ulcerative colitis
  • lymph node metastasis
  • high dose
  • patients with inflammatory bowel disease
  • squamous cell carcinoma